72
Participants
Start Date
February 29, 2016
Primary Completion Date
January 10, 2018
Study Completion Date
January 10, 2018
Placebo
Single dose i.v.
ABY-035 i.v.
Single dose i.v.
ABY-035 s.c.
Single dose s.c.
Covance Clinical Research Unit Ltd., Leeds
Covance and Royal Liverpool University Hospital Clinical Research Unit, Liverpool
Imperial Centre for Translational and Experimental Medicine Imperial College Healthcare NHS Trust Hammersmith Hospital, London
Medicines Evaluation Unit Ltd, Manchester